Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study
A pandemic designated as Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. Up to date, there is no efficient biomarker for the timely prediction of the disease progression in patients. To analyze the inflammatory profi...
Saved in:
| Main Authors: | Yalan Yu, Tao Liu, Liang Shao, Xinyi Li, Colin K. He, Muhammad Jamal, Yi Luo, Yingying Wang, Yanan Liu, Yufeng Shang, Yunbao Pan, Xinghuan Wang, Fuling Zhou |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Taylor & Francis Group
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/aeda50ee6d614fe1a96874fcbbb71bde |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study
by: Guido Primiano, et al.
Published: (2021) -
Salivary Biomarkers in Alzheimer´s Disease
by: Santos,Gustavo A. A, et al.
Published: (2020) -
Role of Serum Uromodulin in the Early Diagnosis of Chronic Kidney Disease
by: Genov D., et al.
Published: (2021) -
The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women
by: Natalia Serhiivna Mykhailovska, et al.
Published: (2020) -
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
by: Sara Fuentelsaz-Romero, et al.
Published: (2021)